INTRATHECAL BACLOFEN - DOES TOLERANCE OCCUR

被引：44

作者：

AKMAN, MN ^{[1
]}

LOUBSER, PG ^{[1
]}

DONOVAN, WH ^{[1
]}

ONEILL, ME ^{[1
]}

ROSSI, CD ^{[1
]}

机构：

[1] INST REHABIL & RES,1333 MOURSUND AVE,HOUSTON,TX 77030

来源：

PARAPLEGIA | 1993年 / 31卷 / 08期

关键词：

INTRATHECAL BACLOFEN; SPASTICITY; SPINAL CORD INJURY; TOLERANCE;

D O I：

10.1038/sc.1993.84

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Concern over the development of tolerance in patients on continuous intrathecal baclofen therapy has arisen as this new form of treatment for spasticity has gained wider use. We have studied time-dose relationships in 18 spinal cord injured patients who have undergone intrathecal baclofen infusion pump implantation since February 1988 in our facility. Our data show that there was a significant increase in baclofen dosage needed to control spasticity during the first 12 months post implantation. After 12 months, however, no significant change in dosage requirement was detected. In addition, there was no significant difference between completely and incompletely spinal cord injured patients with regard to both the initial dose and the tolerance trend.

引用

页码：516 / 520

页数：5

共 15 条

[11] Meythaler J.M., Steers W.D., Tuel S.M., Cross L.L., Haworth C.S., Continuous intrathecal baclofen inspinal cord spasticity, Am J Phys Med Rehabil, 71, pp. 321-327, (1992)
[12] Stevens C.W., Yaksh T.L., Potency of infused spinal anti-nociceptive agents is inversely related tomagnitude of tolerance after continuous infusion, J Pharmacol Exp Ther, 250, 1, pp. 321-327, (1989)
[13] Price G.W., Wilkin G.P., Turnbull M.J., Bowery N.G., Are baclofen-sensitive GABA-B receptors presenton primary afferent terminals of the spinal cord?, Nature, 307, pp. 71-74, (1984)
[14] Golstein A., Aronow L., Kalman S.M., Principles of Drug Action, pp. 459-468, (1974)
[15] Penn R.D., Kroin J.S., Intrathecal baclofen alleviates spinal cord spasticity, Lancet, 1, (1984)

← 1 2 →